$13,409.17 consulting Payment -- Johnson & Johnson to Dr. John Anderson

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

This payment of $13,409.17 from Johnson & Johnson to Dr. John Anderson, a dermatologist in Springfield, MA, was for consulting services on May 31, 2025. The Sunshine Act requires pharmaceutical companies to report payments made to physicians, and this disclosure allows patients to understand potential relationships between their doctors and drug manufacturers. Consulting fees are common as companies seek expert advice from physicians on drug development, medical education, or market insights. The amount, while substantial, is not necessarily out of the ordinary for specialized consulting work in a medical field, especially if it involved significant time or expertise. However, any payment from a pharmaceutical company to a physician can raise questions about potential conflicts of interest. It's important to remember that these payments do not automatically mean a doctor's judgment is compromised. Many physicians engage in these relationships to stay informed about new treatments and contribute to medical advancement. For context, the average annual payment to dermatologists can vary widely, but consulting fees of this magnitude are not uncommon for specific projects. Patients should view this information as a tool to foster open communication with their doctor. Understanding these relationships helps ensure that treatment decisions are based solely on the patient's best medical interests, not influenced by financial ties. Transparency through the Open Payments system empowers patients to have more informed discussions about their care.

Patient Guidance: What This Payment Means for You

It's understandable to have questions when you see your doctor has received payments from pharmaceutical companies. The best approach is to have an open conversation. You can start by asking, 'I saw on the Open Payments website that you received a consulting fee from Johnson & Johnson. Could you tell me more about the nature of that work?' This payment was for consulting, which often involves sharing expertise on medical topics or product development. While it's important to be aware of potential influences, such payments don't automatically mean your care will be affected. Many physicians participate in these arrangements to stay current with medical advancements. At your next appointment, you might ask, 'How do you stay up-to-date on the latest treatments, and how do you decide which ones are best for me?' If you have specific concerns about a prescribed medication or treatment plan, discuss them directly with your doctor. Routine payments for consulting or speaking engagements are common, but if a payment seems exceptionally large or frequent, or if you feel your doctor isn't addressing your concerns transparently, that might warrant further consideration.

Payment Context: Is This Amount Normal?

Dermatology is a specialty where physicians often engage with pharmaceutical companies, particularly concerning new treatments for skin conditions. Payments for consulting can range from a few hundred to several thousand dollars, depending on the scope of work and the physician's expertise. While not all dermatologists receive payments, a significant portion do engage in some form of industry relationship. This $13,409 payment falls within a range that can be considered substantial for consulting work in this field.

Regulatory Context: Sunshine Act Requirements

The Sunshine Act, part of the Affordable Care Act, mandates that manufacturers of drugs, medical devices, and biologics report payments and other transfers of value made to physicians and teaching hospitals. These reports are made publicly available through the CMS Open Payments database. Consulting fees are a reportable category, and the threshold for reporting is generally $10 or more. This payment clearly exceeds that threshold and is therefore publicly disclosed. There isn't specific heightened scrutiny for consulting fees versus other types of payments, but all disclosed payments are subject to review and public access.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharma-payments
• dermatology
• consulting-fees
• sunshine-act
• johnson-and-johnson
• physician-payments
• conflict-of-interest

Understanding consulting Payments

Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.

Frequently Asked Questions About This Payment

Does my doctor take pharma money?

You can check if your doctor receives payments from pharmaceutical companies through the Centers for Medicare & Medicaid Services (CMS) Open Payments database. This website allows you to search for physicians by name and NPI (National Provider Identifier). If a doctor has received payments, they will be listed along with the company, amount, and nature of the payment. Seeing a payment doesn't automatically mean your doctor's decisions are biased, but it does provide transparency. It's an opportunity to understand potential relationships and have an open dialogue with your physician about their prescribing practices and how they stay informed about treatments.

Should I worry about this payment?

This specific payment of $13,409.17 to Dr. Anderson for consulting is a significant amount, but it's important to view it in context. Consulting fees are a common way for pharmaceutical companies to leverage physician expertise. It doesn't inherently mean your care will be compromised. However, it does highlight a financial relationship that warrants awareness. Consider it an opportunity to ensure your treatment decisions are based on your individual needs. If you have concerns about a particular prescription or treatment, discuss them openly with Dr. Anderson. Transparency is key, and this payment is part of that transparency.

What types of pharma payments are most concerning?

While all payments are disclosed, certain types can raise more questions. Large, frequent payments for speaking engagements or consulting, especially if they seem disconnected from genuine educational or advisory roles, can be concerning. Payments tied directly to the promotion of a specific drug, or significant 'research' payments where the research is minimal or the results are not published, might warrant closer scrutiny. However, payments for legitimate research, medical education, or advisory boards where the physician provides valuable expertise are often considered standard practice. The key is understanding the purpose and value of the service provided in exchange for the payment.

How do I talk to my doctor about pharma relationships?

Start by being direct and non-accusatory. You could say, 'I noticed on the Open Payments website that you've received payments from pharmaceutical companies. Can you help me understand what these relationships involve?' You might also ask, 'How do you ensure that your treatment recommendations are always in my best interest, regardless of any industry relationships?' Another good question is, 'How do you stay informed about new treatments, and what is your process for deciding which ones are most appropriate for patients like me?' Frame it as a desire to understand their practice better and ensure you're both on the same page about your care.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for doctors to accept payments from pharmaceutical companies, provided these payments are accurately reported under the Sunshine Act. The Act requires companies to disclose payments for things like consulting, speaking, research, meals, travel, and ownership interests. The purpose of the Act is to increase transparency, allowing patients and the public to see these financial relationships. It does not prohibit payments, but it does require them to be disclosed. Doctors are expected to maintain their professional judgment and ethical obligations to their patients above any financial considerations.

Does pharma money affect what my doctor prescribes?

Research suggests that financial relationships between physicians and pharmaceutical companies can influence prescribing patterns. Doctors who receive payments may be more likely to prescribe the drugs manufactured by the companies they have relationships with. However, this influence can be subtle and doesn't mean all doctors are biased. Many physicians maintain their professional integrity. The Open Payments data is designed to help patients be aware of these potential influences and have informed discussions with their doctors about treatment options, ensuring decisions are based on medical evidence and patient needs.

How does this compare to other doctors in this specialty?

Dermatology is a field where physicians often have relationships with pharmaceutical companies due to the development of new treatments for skin conditions. While not every dermatologist receives payments, a notable percentage do. Payments can range from small amounts for meals to larger sums for consulting or speaking. This $13,409.17 payment for consulting is on the higher end for a single transaction but not unheard of for specialized advisory work. It's more than a nominal amount, suggesting a more involved relationship than just occasional meals or minor educational events. Comparing it to averages requires looking at the full dataset for dermatology, but it indicates Dr. Anderson is likely among those who engage more actively with the industry.

Related Reports

• View Dr. John Anderson's full payment report
• Johnson & Johnson full spending report
• Browse all Dermatology payments
• Browse all payments in Massachusetts
• Search for other payments